Cancer News
OncoLink Cancer News - HealthDay

Lymphoid Neogenesis Identified in Melanoma Metastases

Tuesday, July 31, 2012 (Last Updated: 08/01/2012)

TUESDAY, July 31 (HealthDay News) -- Lymphoid follicles, comprising clusters of B lymphocytes and follicular dendritic cells (DCs) associated with high endothelial venules (HEVs), are found in melanoma metastases, but not in primary melanomas, according to a study published online July 31 in Cancer Research.

Arcadi Cipponi, Ph.D., from the Université Catholique de Louvain in Belgium, and colleagues investigated whether ectopic lymphoid structures, previously reported in primary lung, breast, and germline cancers, are present in melanoma.

The researchers found that, in seven of 29 cutaneous metastases from melanoma patients, lymphoid follicles, comprising clusters of B lymphocytes and follicular DCs associated with HEVs, and clusters of T cells and mature DCs were observed. Germinal centers were observed in some follicles. Follicles were not seen in primary melanomas but many primary tumors contained HEVs. Clonal amplification, somatic mutation, and isotype switching were revealed on analysis of immunoglobulin genes in the B cells of microdissected follicles.

"Taken together, our findings show the existence of lymphoid neogenesis in melanoma and suggest that the presence of functional ectopic lymphoid structures in direct contact with the tumor makes the local development of antimelanoma B- and T-cell responses possible," the authors write.

Full Text (subscription or payment may be required)

Specialties Hematology & Oncology

Copyright © 2012 HealthDay. All rights reserved.

I Wish You Knew

About life with cancer

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More